These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 20026359)

  • 1. Phospholipid and sphingolipid metabolism in Leishmania.
    Zhang K; Beverley SM
    Mol Biochem Parasitol; 2010 Apr; 170(2):55-64. PubMed ID: 20026359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania.
    Zhang K; Pompey JM; Hsu FF; Key P; Bandhuvula P; Saba JD; Turk J; Beverley SM
    EMBO J; 2007 Feb; 26(4):1094-104. PubMed ID: 17290222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipids in parasitic protozoa.
    Zhang K; Bangs JD; Beverley SM
    Adv Exp Med Biol; 2010; 688():238-48. PubMed ID: 20919659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis.
    Zhang K; Hsu FF; Scott DA; Docampo R; Turk J; Beverley SM
    Mol Microbiol; 2005 Mar; 55(5):1566-78. PubMed ID: 15720561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids are essential for differentiation but not growth in Leishmania.
    Zhang K; Showalter M; Revollo J; Hsu FF; Turk J; Beverley SM
    EMBO J; 2003 Nov; 22(22):6016-26. PubMed ID: 14609948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of host sphingomyelin is essential for Leishmania virulence.
    Zhang O; Wilson MC; Xu W; Hsu FF; Turk J; Kuhlmann FM; Wang Y; Soong L; Key P; Beverley SM; Zhang K
    PLoS Pathog; 2009 Dec; 5(12):e1000692. PubMed ID: 20011126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sphinx and the egg: Evolutionary enigmas of the (glyco)sphingolipid biosynthetic pathway.
    Biran A; Santos TCB; Dingjan T; Futerman AH
    Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Apr; 1869(3):159462. PubMed ID: 38307322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perilous path: the inborn errors of sphingolipid metabolism.
    Dunn TM; Tifft CJ; Proia RL
    J Lipid Res; 2019 Mar; 60(3):475-483. PubMed ID: 30683667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evolution of the enzymes involved in the sphingolipid metabolism of Leishmania: selection pressure in relation to functional divergence and conservation.
    Mandlik V; Shinde S; Singh S
    BMC Evol Biol; 2014 Jun; 14():142. PubMed ID: 24951280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis.
    Mina JGM; Denny PW
    Parasitology; 2018 Feb; 145(2):134-147. PubMed ID: 28637533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity.
    Denny PW; Goulding D; Ferguson MA; Smith DF
    Mol Microbiol; 2004 Apr; 52(2):313-27. PubMed ID: 15066023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine salvage in Leishmania: complex or simple by design?
    Boitz JM; Ullman B; Jardim A; Carter NS
    Trends Parasitol; 2012 Aug; 28(8):345-52. PubMed ID: 22726696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism in Trypanosoma cruzi: A review.
    Booth LA; Smith TK
    Mol Biochem Parasitol; 2020 Nov; 240():111324. PubMed ID: 32961207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rafts and sphingolipid biosynthesis in the kinetoplastid parasitic protozoa.
    Denny PW; Smith DF
    Mol Microbiol; 2004 Aug; 53(3):725-33. PubMed ID: 15255887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making Sense of the Yeast Sphingolipid Pathway.
    Megyeri M; Riezman H; Schuldiner M; Futerman AH
    J Mol Biol; 2016 Dec; 428(24 Pt A):4765-4775. PubMed ID: 27664439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic pathways required for the intracellular survival of Leishmania.
    McConville MJ; Naderer T
    Annu Rev Microbiol; 2011; 65():543-61. PubMed ID: 21721937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid pathway enzymes modulate cell fate and immune responses.
    Molino S; Tate E; McKillop WM; Medin JA
    Immunotherapy; 2017 Nov; 9(14):1185-1198. PubMed ID: 29067886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies.
    Suzuki E; Tanaka AK; Toledo MS; Levery SB; Straus AH; Takahashi HK
    Biochim Biophys Acta; 2008 Mar; 1780(3):362-9. PubMed ID: 17976917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid homeostasis in the web of metabolic routes.
    Aguilera-Romero A; Gehin C; Riezman H
    Biochim Biophys Acta; 2014 May; 1841(5):647-56. PubMed ID: 24184514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing de novo synthesis and salvage of lipids by Leishmania amastigotes.
    Zhang K
    Curr Opin Microbiol; 2021 Oct; 63():98-103. PubMed ID: 34311265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.